Sonoma Pharmaceuticals Announce Collaboration with EMC Pharma to Expand Eye Care Products
Sonoma Pharmaceuticals and EMC Pharma Partnership
BOULDER, CO / ACCESSWIRE / September 11, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader, has announced an important collaboration with EMC Pharma to co-market an expanded product line in eye care.
Driving Market Presence
This partnership seeks to enhance the market reach of Sonoma’s innovative pharmaceuticals, leveraging EMC Pharma’s expertise in the healthcare market.
Benefits of the Collaboration
- Development of new treatment options for eye care.
- Improved patient outcomes through innovative formulations.
- Joint marketing strategies to boost product visibility.
Through this collaboration, the companies are committed to strengthening the eye care portfolio, ultimately benefiting patients and healthcare providers alike.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.